Blog Browse - Two Blokes Trading

Posted Apr 30 by Two Blokes

Investors will likely focus on the sales performance of Jazz Pharmaceuticals' key neuroscience drugs, Xywav an

Posted Apr 30 by Two Blokes

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. Th

Posted Apr 30 by Two Blokes

TSN's Q2 fiscal 2025 results are likely to reflect gains from growing consumer demand for protein and expansio

Posted Apr 30 by Two Blokes

Automatic Data Processing beat Wall Street expectations for third-quarter revenue on Wednesday, benefiting fro

Posted Apr 30 by Two Blokes

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financi

Posted Apr 30 by Two Blokes

Private sector payrolls rose by just 62,000 for the month, the smallest gain since July 2024, down from 147,00

Posted Apr 30 by Two Blokes

AstraZeneca PLC (LSE:AZN) investors looking beyond the short-term noise of Medicare reform and currency headwi

Posted Apr 30 by Two Blokes

The figure reported on Wednesday is well below economists' estimates of 115,000 jobs and also down sharply fro

Posted Apr 30 by Two Blokes

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting

Posted Apr 30 by Two Blokes

Key takeaways: Macro Chain Index issues first buy signal since 2022, hinting at a new Bitcoin bull run. RSI cr

Posted Apr 30 by Two Blokes

PLYMOUTH MEETING, Pa. , April 30, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on

Posted Apr 30 by Two Blokes

BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI) ("Xeriant" or "the Company"),